448
Participants
Start Date
November 28, 2016
Primary Completion Date
August 27, 2018
Study Completion Date
November 16, 2018
Dupilumab SAR231893 (REGN668)
"Pharmaceutical form: Solution~Route of administration: Subcutaneous"
Placebo
"Pharmaceutical form: Solution~Route of administration: Subcutaneous"
Mometasone furoate nasal spray
"Pharmaceutical form: Suspension~Route of administration: Intranasal"
Investigational Site Number 0560003, Brussels
Investigational Site Number 0360003, Prahran
Investigational Site Number 0360001, Parkville
Investigational Site Number 0360002, Clayton
Investigational Site Number 0560002, Leuven
Investigational Site Number 0360004, Herston
Investigational Site Number 0320003, Mendoza
Investigational Site Number 0360005, Murdoch
Investigational Site Number 0560001, Ghent
Investigational Site Number 8400024, The Bronx
Investigational Site Number 7240003, Jerez de la Frontera
Investigational Site Number 8400003, Pittsburgh
Investigational Site Number 7920013, Bursa
Investigational Site Number 8400013, Bethlehem
Investigational Site Number 8400005, Philadelphia
Investigational Site Number 3760003, Nahariya
Investigational Site Number 7240002, Madrid
Investigational Site Number 8400016, North Charleston
Investigational Site Number 4840001, Chihuahua City
Investigational Site Number 4840005, Chihuahua City
Investigational Site Number 7920010, Istanbul
Investigational Site Number 4840004, Durango
Investigational Site Number 7920009, Istanbul
Investigational Site Number 7920003, Istanbul
Investigational Site Number 7920001, Istanbul
Investigational Site Number 7920002, Istanbul
Investigational Site Number 7920006, Izmir
Investigational Site Number 8400019, Birmingham
Investigational Site Number 7920007, Izmir
Investigational Site Number 3760001, Hadera
Investigational Site Number 8400002, Louisville
Investigational Site Number 7240007, Seville
Investigational Site Number 4840002, Guadalajara
Investigational Site Number 7240009, Valencia
Investigational Site Number 3760002, Petah Tikva
Investigational Site Number 3760004, Tel Litwinsky
Investigational Site Number 7920011, Rize
Investigational Site Number 8400007, Milwaukee
Investigational Site Number 8400014, Kansas City
Investigational Site Number 4840003, Monterrey
Investigational Site Number 3760005, Rehovot
Investigational Site Number 8400006, Denver
Investigational Site Number 8400017, Colorado Springs
Investigational Site Number 8400009, Salt Lake City
Investigational Site Number 8400004, Rolling Hills Estates
Investigational Site Number 8400008, Huntington Beach
Investigational Site Number 8400011, Fresno
Investigational Site Number 8400012, Walnut Creek
Investigational Site Number 8400010, Bellevue
Investigational Site Number 6430006, Moscow
Investigational Site Number 6430003, Odintsovo
Investigational Site Number 6430001, Yaroslavl
Investigational Site Number 6430002, Saint Petersburg
Investigational Site Number 6430005, Stavropol
Investigational Site Number 1520009, Quillota
Investigational Site Number 1520005, Santiago
Investigational Site Number 1520011, Santiago
Investigational Site Number 1520008, Santiago
Investigational Site Number 1520006, Santiago
Investigational Site Number 1520001, Santiago
Investigational Site Number 1520014, Santiago
Investigational Site Number 8400022, New Haven
Investigational Site Number 8400021, Boston
Investigational Site Number 0320006, Buenos Aires
Investigational Site Number 0320004, Buenos Aires
Investigational Site Number 0320005, Caba
Investigational Site Number 0320001, Caba
Investigational Site Number 0320007, Caba
Investigational Site Number 0320008, Rosario
Investigational Site Number 0320002, San Miguel de Tucumán
Investigational Site Number 1240007, Kingston
Investigational Site Number 1240002, Montreal
Investigational Site Number 1240006, Montreal
Investigational Site Number 1240005, Ottawa
Investigational Site Number 1240003, Québec
Investigational Site Number 1240004, Québec
Investigational Site Number 1240008, Trois-Rivières
Investigational Site Number 1240001, Vancouver
Investigational Site Number 1520010, San Fernando
Investigational Site Number 1520003, Talca
Investigational Site Number 1520007, Viña del Mar
Investigational Site Number 3920004, Bunkyō City
Investigational Site Number 3920009, Bunkyō City
Investigational Site Number 3920026, Bunkyō City
Investigational Site Number 3920006, Chiyoda-Ku
Investigational Site Number 3920024, Fukuoka
Investigational Site Number 3920010, Hirakata-Shi
Investigational Site Number 3920011, Hiroshima
Investigational Site Number 3920007, Iida-Shi
Investigational Site Number 3920015, Inzai-Shi
Investigational Site Number 3920012, Itabashi-Ku
Investigational Site Number 3920014, Izumisano
Investigational Site Number 3920016, Kawasaki-Shi
Investigational Site Number 3920020, Kitakyushu-Shi
Investigational Site Number 3920027, Kitakyushu-Shi
Investigational Site Number 3920002, Kumamoto
Investigational Site Number 3920021, Kumamoto
Investigational Site Number 3920003, Kyoto
Investigational Site Number 3920023, Meguro-Ku
Investigational Site Number 3920013, Moriguchi-Shi
Investigational Site Number 3920025, Okayama
Investigational Site Number 3920018, Osaka
Investigational Site Number 3920017, Ōta-ku
Investigational Site Number 3920005, Sendai
Investigational Site Number 3920022, Sendai
Investigational Site Number 3920001, Shimonoseki-Shi
Investigational Site Number 3920029, Shinagawa-Ku
Investigational Site Number 3920030, Shinjyuku-Ku
Investigational Site Number 3920028, Takatsuki-Shi
Investigational Site Number 3920019, Yoshida-Gun
Investigational Site Number 6200004, Aveiro
Investigational Site Number 6200006, Guimarães
Investigational Site Number 6200002, Lisbon
Investigational Site Number 6200007, Matosinhos Municipality
Investigational Site Number 6200001, Porto
Investigational Site Number 6200005, Viana do Castelo
Investigational Site Number 7240001, Barcelona
Investigational Site Number 7240006, Barcelona
Investigational Site Number 7520002, Lund
Investigational Site Number 7520001, Stockholm
Investigational Site Number 7920004, Ankara
Investigational Site Number 7920005, Ankara
Investigational Site Number 7920008, Ankara
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY